Limmroth, V, Barkhof, F, Desem, N, Diamond, M P & Tachas, G 2014, ' CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS ', Neurology, vol. 83, no. 20, pp. 1780-1788 . https://doi.org/10.1212/WNL.0000000000000926 Neurology Neurology, 83(20), 1780-1788. Lippincott Williams and Wilkins